+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report by Type (Wearables, Mobile-Based Applications, Sensors), Clinical Practice (Diagnostic, Monitoring, Predictive & Prognostic), End-Use, and Region with Growth Forecasts, 2025-2030- Product Image
Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report by Type (Wearables, Mobile-Based Applications, Sensors), Clinical Practice (Diagnostic, Monitoring, Predictive & Prognostic), End-Use, and Region with Growth Forecasts, 2025-2030- Product Image
New

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report by Type (Wearables, Mobile-Based Applications, Sensors), Clinical Practice (Diagnostic, Monitoring, Predictive & Prognostic), End-Use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 5990571
Description Jump to:
The Psychiatric Digital Biomarkers Market was valued at USD 631.3 million in 2024, and is projected to reach USD 2.29 billion by 2030, rising at a CAGR of 24.40%. The rising prevalence of mental health disorders, advancements in digital health technologies, and growing demand for personalized medicine drive the market. For instance, according to the World Health Organization, approximately 280 million individuals across the globe have depression. Depression is about 50% more common among women than men.

The rising adoption of wearable devices and mobile health apps in mental healthcare contributes to market growth. Moreover, according to the International Data Corporation (IDC), shipments of wearable devices increased by 2.6% across the globe in the third quarter of 2023 compared to the previous year, setting a new third-quarter record with a total of 148.4 million units.

Moreover, the global burden of mental health disorders is on the rise, with conditions such as depression, anxiety, bipolar disorder, and schizophrenia affecting millions of individuals worldwide. In 2023, Mental Health America, Inc. found that 20.17% of youths aged 12-17 had encountered a major depressive episode, with 15% suffering severe impairment affecting daily activities. This increasing prevalence is driving the need for more effective tools to monitor and manage mental health conditions, leading to a growing demand for psychiatric digital biomarkers.

Technological advancements in digital health technologies have revolutionized the field of mental healthcare. Innovations such as artificial intelligence (AI), machine learning, and data analytics enable the development of sophisticated digital biomarkers that provide valuable insights into an individual’s mental health status. AI-powered algorithms analyze data from smartphone sensors to detect changes in behavior patterns that indicate early signs of a mental health crisis. For instance, in September 2022, Feel Therapeutics Inc., a digital biomarkers and therapeutics developer to bring objective data in mental health, introduced the Digital Precision Medicine Platform. With this platform, the company is able to collect clinically valuable data points passively and on a 24/7 basis to generate real-world evidence (RWE) and discover novel digital biomarkers and endpoints.

Global Psychiatric Digital Biomarkers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global psychiatric digital biomarkers market report based on type, clinical practice, end-use, and region.

Type Outlook (Revenue, USD Million, 2018-2030)

  • Wearable
  • Mobile based Applications
  • Sensors
  • Others

Clinical Practice Outlook (Revenue, USD Million, 2018-2030)

  • Diagnostic Psychiatric Digital Biomarkers
  • Monitoring Psychiatric Digital Biomarkers
  • Predictive and Prognostic Psychiatric Digital Biomarkers
  • Others

End-use Outlook (Revenue, USD Million, 2018-2030)

  • Healthcare companies
  • Healthcare Providers
  • Payers
  • Others (Patient, caregivers)

Regional Outlook (Revenue, USD Million, 2018-2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Clinical Practice outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Psychiatric Digital Biomarkers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Psychiatric Digital Biomarkers: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
Chapter 4. Psychiatric Digital Biomarkers Market Segment Analysis, by Type, 2018-2030 (USD Million)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Psychiatric Digital Biomarkers Market, by Type, 2018 to 2030
4.5. Wearable
4.5.1. Wearable Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Mobile based Applications
4.6.1. Mobile based Applications Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Sensors
4.7.1. Sensors Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.8. Others
4.8.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Psychiatric Digital Biomarkers Market Segment Analysis, by Clinical Practice, 2018-2030 (USD Million)
5.1. Definition and Scope
5.2. Clinical Practice Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2018 to 2030
5.5. Diagnostic Psychiatric Digital Biomarkers
5.5.1. Diagnostic Psychiatric Digital Biomarkers Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Monitoring Psychiatric Digital Biomarkers
5.6.1. Monitoring Psychiatric Digital Biomarkers Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Predictive and Prognostic Psychiatric Digital Biomarkers
5.7.1. Predictive and Prognostic Psychiatric Digital Biomarkers Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Psychiatric Digital Biomarkers Market Segment Analysis, by End Use, 2018-2030 (USD Million)
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. Global Psychiatric Digital Biomarkers Market, by End Use, 2018 to 2030
6.5. Healthcare companies
6.5.1. Healthcare companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Healthcare Providers
6.6.1. Healthcare Providers market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Payers
6.7.1. Payers market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Psychiatric Digital Biomarkers Market Segment Analysis, by Region, 2018-2030 (USD Million)
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Regional Market Snapshot
7.4. Psychiatric Digital Biomarkers Market Share by Region, 2024 & 2030:
7.5. North America
7.5.1. North America psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.5.2. U.S.
7.5.2.1. U.S. psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.5.3. Canada
7.5.3.1. Canada psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Mexico psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.6. Europe
7.6.1. Europe psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.6.2. UK
7.6.2.1. UK psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.6.3. Germany
7.6.3.1. Germany psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.6.4. France
7.6.4.1. France psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.6.5. Italy
7.6.5.1. Italy psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.6.6. Spain
7.6.6.1. Spain psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.6.7. Norway
7.6.7.1. Norway psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.6.8. Sweden
7.6.8.1. Sweden psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.6.9. Denmark
7.6.9.1. Denmark psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.7.2. China
7.7.2.1. China psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.7.3. India
7.7.3.1. India psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Argentina psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE psychiatric digital biomarkers market, 2018-2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait psychiatric digital biomarkers market, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. Koneksa Health
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Biogen
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Empatica Inc
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. VivoSense
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. IXICO plc
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Sonde Health, Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Clario
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Global psychiatric digital biomarkers market, by region, 2018-2030 (USD Million)
Table 4 Global psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 5 Global psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 6 Global psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 7 North America psychiatric digital biomarkers market, by country, 2018-2030 (USD Million)
Table 8 North America psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 9 North America psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 10 North America psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 11 U.S. psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 12 U.S. psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 13 U.S. psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 14 Canada psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 15 Canada psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 16 Canada psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 17 Mexico psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 18 Mexico psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 19 Mexico psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 20 Europe psychiatric digital biomarkers market, by country, 2018-2030 (USD Million)
Table 21 Europe psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 22 Europe psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 23 Europe psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 24 Germany psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 25 Germany psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 26 Germany psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 27 UK psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 28 UK psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 29 UK psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 30 France psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 31 France psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 32 France psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 33 Italy psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 34 Italy psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 35 Italy psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 36 Spain psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 37 Spain psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 38 Spain psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 39 Denmark psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 40 Denmark psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 41 Denmark psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 42 Sweden psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 43 Sweden psychiatric digital biomarkers market, by clinical practice, 2018-2030, (USD Million
Table 44 Sweden psychiatric digital biomarkers market, by end use, 2018-2030, (USD Million
Table 45 Norway psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 46 Norway psychiatric digital biomarkers market, by clinical practice, 2018-2030, (USD Million
Table 47 Norway psychiatric digital biomarkers market, by end use, 2018-2030, (USD Million
Table 48 Asia Pacific psychiatric digital biomarkers market, by country, 2018-2030 (USD Million)
Table 49 Asia Pacific psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 50 Asia Pacific psychiatric digital biomarkers market, by clinical practice, 2018-2030, (USD Million
Table 51 Asia Pacific psychiatric digital biomarkers market, by end use, 2018-2030, (USD Million
Table 52 China psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 53 China psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 54 China psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 55 Japan psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 56 Japan psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 57 Japan psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 58 India psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 59 India psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 60 India psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 61 South Korea psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 62 South Korea psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 63 South Korea psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 64 Australia psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 65 Australia psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 66 Australia psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 67 Thailand psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 68 Thailand psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 69 Thailand psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 70 Latin America psychiatric digital biomarkers market, by country, 2018-2030 (USD Million)
Table 71 Latin America psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 72 Latin America psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 73 Latin America psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 74 Brazil psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 75 Brazil psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 76 Brazil psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 77 Argentina psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 78 Argentina psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 79 Argentina psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 80 MEA psychiatric digital biomarkers market, by country, 2018-2030 (USD Million)
Table 81 MEA psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 82 MEA psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 83 MEA psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 84 South Africa psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 85 South Africa psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 86 South Africa psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 87 Saudi Arabia psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 88 Saudi Arabia psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 89 Saudi Arabia psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 90 UAE psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 91 UAE psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 92 UAE psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
Table 93 Kuwait psychiatric digital biomarkers market, by type, 2018-2030 (USD Million)
Table 94 Kuwait psychiatric digital biomarkers market, by clinical practice, 2018-2030 (USD Million)
Table 95 Kuwait psychiatric digital biomarkers market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Psychiatric digital biomarkers market outlook
Figure 9 Psychiatric digital biomarkers competitive insights
Figure 10 Ancillary market outlook
Figure 11 Psychiatric digital biomarkers market driver impact
Figure 12 Psychiatric digital biomarkers market restraint impact
Figure 13 Porter’s Analysis
Figure 14 PESTLE Analysis
Figure 15 Psychiatric digital biomarkers market: Type movement analysis
Figure 16 Psychiatric digital biomarkers market: Type outlook and key takeaways
Figure 17 Wearable market estimates and forecast, 2018-2030
Figure 18 Mobile based Applications market estimates and forecast, 2018-2030
Figure 19 Sensors market estimates and forecast, 2018-2030
Figure 20 Others market estimates and forecast, 2018-2030
Figure 21 Psychiatric digital biomarkers market: Clinical Practice movement analysis
Figure 22 Psychiatric digital biomarkers market: Clinical Practice outlook and key takeaways
Figure 23 Diagnostic Psychiatric Digital Biomarkers market estimates and forecasts, 2018-2030
Figure 24 Predictive and Prognostic Psychiatric Digital Biomarkers market estimates and forecasts,2018-2030
Figure 25 Others market estimates and forecast, 2018-2030
Figure 26 Psychiatric digital biomarkers market: End Use movement analysis
Figure 27 Psychiatric digital biomarkers market: End Use outlook and key takeaways
Figure 28 Healthcare companies market estimates and forecasts, 2018-2030
Figure 29 Healthcare Providers market estimates and forecasts, 2018-2030
Figure 30 Payers market estimates and forecasts, 2018-2030
Figure 31 Others market estimates and forecasts, 2018-2030
Figure 32 Global psychiatric digital biomarkers market: Regional movement analysis
Figure 33 Global psychiatric digital biomarkers market: Regional outlook and key takeaways
Figure 34 North America psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Key country dynamics
Figure 36 U.S. psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Key country dynamics
Figure 38 Canada psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Key country dynamics
Figure 40 Mexico psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Europe psychiatric digital biomarkers market estimates and forecasts, 2018 - 2030, (USD million)
Figure 42 Key country dynamics
Figure 43 UK psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Key country dynamics
Figure 45 Germany psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Key country dynamics
Figure 47 Spain psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Key country dynamics
Figure 49 France psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Key country dynamics
Figure 51 Italy psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Key country dynamics
Figure 53 Norway psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Key country dynamics
Figure 55 Denmark psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Key country dynamics
Figure 57 Sweden psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Asia Pacific psychiatric digital biomarkers market estimates and forecasts, 2018 - 2030, (USD million)
Figure 59 Key country dynamics
Figure 60 Japan psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 Key country dynamics
Figure 62 China psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 Key country dynamics
Figure 64 India psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 65 Key country dynamics
Figure 66 Australia psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Key country dynamics
Figure 68 South Korea psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 69 Key country dynamics
Figure 70 Thailand psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Latin America psychiatric digital biomarkers market estimates and forecasts, 2018 - 2030, (USD million)
Figure 72 Key country dynamics
Figure 73 Brazil psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 Argentina psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 76 MEA psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 77 Key country dynamics
Figure 78 South Africa psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Saudi Arabia psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 81 Key country dynamics
Figure 82 UAE psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 83 Key country dynamics
Figure 84 Kuwait psychiatric digital biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Figure 85 Key company categorization
Figure 86 Heat map analysis 2024

Companies Mentioned

The major companies profiled in this Psychiatric Digital Biomarkers market report include:
  • Koneksa Health
  • Biogen
  • Empatica Inc.
  • VivoSense
  • IXICO plc
  • Sonde Health, Inc.
  • Clario

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 631.3 Million
Forecasted Market Value ( USD ) by 2030 $ 2290 Million
Compound Annual Growth Rate24.4%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Digital Neuro Biomarkers Market Size, Share & Trend Analysis Report By Type, By Clinical Practice, By End Use, By Region, and Segment Forecasts, 2025 - 2030 - Product Image

Digital Neuro Biomarkers Market Size, Share & Trend Analysis Report By Type, By Clinical Practice, By End Use, By Region, and Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By Therapeutic Area, By End-use (Healthcare Companies), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By Therapeutic Area, By End-use (Healthcare Companies), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Psychiatric Digital Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Psychiatric Digital Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Digital Biomarkers Market by Type, Therapeutic Area, End-Use - Global Forecast 2025-2030 - Product Image

Digital Biomarkers Market by Type, Therapeutic Area, End-Use - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Digital Biomarkers Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product, Purpose of Solution, Type of Biomarker, Therapeutic Area, Business Model and Key Geographical Regions - Product Image

Digital Biomarkers Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product, Purpose of Solution, Type of Biomarker, Therapeutic Area, Business Model and Key Geographical Regions

  • Report
  • 369 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.